RGS2 C1114G polymorphism and body weight gain in hypertensive patients

Metabolism: Clinical and Experimental

Volumn 57, Issue 3, 2008, Pages 421-427

  Sartori, Michelangelo ^a   Ceolotto, Giulio ^b   Dorigatti, Francesca ^b   Mos, Lucio ^c   Santonastaso, Massimo ^c   Bratti, Paolo ^b   Papparella, Italia ^b   Semplicini, Andrea ^b   Palatini, Paolo ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Town Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RGS2 PROTEIN;

ADULT; ALLELE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENE FREQUENCY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; WEIGHT GAIN;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; ALLELES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; OVERWEIGHT; POLYMORPHISM, GENETIC; RGS PROTEINS; SEX CHARACTERISTICS; WEIGHT GAIN;

EID: 38849176257     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.10.021     Document Type: Article

References (35)

1. Wild S.H., and Byrne C.D. ABC of obesity. Risk factors for diabetes and coronary heart disease. BMJ 333 (2006) 1009-1011
2. Chuang S.Y., Chou P., Hsu P.F., Cheng H.M., Tsai S.T., Lin I.F., et al. Presence and progression of abdominal obesity are predictors of future high blood pressure and hypertension. Am J Hypertens 19 (2006) 788-795
3. Walley A.J., Blakemore A.I., and Froguel P. Genetics of obesity and the prediction of risk for health. Hum Mol Genet 15 (2006) R124-R130
4. Perusse L., Rankinen T., Zuberi A., Chagnon Y.C., Weisnagel S.J., Argyropoulos G., et al. The human obesity gene map: the 2004 update. Obes Res 13 (2005) 381-490
5. Kehrl J.H., and Sinnarajah S. RGS2: a multifunctional regulator of G-protein signalling. Int J Biochem Cell Biol 34 (2002) 432-438
6. Heximer S.P., Watson N., Linder M.E., Blumer K.J., and Hepler J.R. RGS2/G0S8 is a selective inhibitor of Gqα function. Proc Natl Acad Sci U S A 94 (1997) 14389-14393
7. Imagawa M., Tsuchiya T., and Nishihara T. Identification of inducible genes at the early stage of adipocyte differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 254 (1999) 299-305
8. Nishizuka M., Honda K., Tsuchiya T., Nishihara T., and Imagawa M. RGS2 promotes adipocyte differentiation in the presence of ligand for peroxisome proliferator-activated receptor γ. J Biol Chem 276 (2001) 29625-29627
9. Eszlinger M., Holzapfel H.P., Voigt C., Arkenau C., and Paschke R. RGS 2 expression is regulated by TSH and inhibits TSH receptor signaling. Eur J Endocrinol 151 (2004) 383-390
10. Freson K., Stolarz K., Aerts R., Brand E., Brand-Herrmann S.M., Kawecka-Jaszcz K., et al. -391 C to G substitution in the regulator of G-protein signalling-2 promoter increases susceptibility to the metabolic syndrome in white European men: consistency between molecular and epidemiological studies. J Hypertens 25 (2007) 117-125
11. Semplicini A., Lenzini L., Sartori M., Papparella I., Calo L.A., Pagnin E., et al. Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II. J Hypertens 24 (2006) 1115-1124
12. Palatini P., Mormino P., Mos L., Mazzer A., Dorigatti F., Zanata G., et al. Microalbuminuria, renal function and development of sustained hypertension: a longitudinal study in the early stage of hypertension. J Hypertens 23 (2005) 175-182
13. Palatini P., Graniero G., Mormino P., Nicolosi L., Mos L., Visentin P., et al. Relation between physical training and ambulatory blood pressure in stage I hypertensive subjects. Results of the HARVEST trial. Circulation 90 (1994) 2870-2876
14. Sartori M., Semplicini A., Siffert W., Mormino P., Mazzer A., Pegoraro F., et al. G-protein beta3-subunit gene 825T allele and hypertension: a longitudinal study in young grade I hypertensives. Hypertension 42 (2003) 909-914
15. Palatini P., Winnicki M., Santonastaso M., Mos L., Longo D., Zaetta V., et al. Prevalence and clinical significance of isolated ambulatory hypertension in young subjects screened for stage 1 hypertension. Hypertension 44 (2004) 170-174
16. Palatini P., Pessina A.C., and Dal Palu C. The Hypertension and Ambulatory Recording Venetia Study (HARVEST): a trial on the predictive value of ambulatory blood pressure monitoring for the development of fixed hypertension in patients with borderline hypertension. High Blood Press 2 (1993) 11-18
17. British Hypertension Society Working Party. Treating mild hypertension. BMJ 298 (1989) 694-698
18. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. Guidelines Subcommittee. J Hypertens 17 (1999) 151-183
19. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., and Flegal K.M. Prevalence of overweight and obesity in the United States 1999-2004. JAMA 295 (2006) 1549-1555
20. Winnicki M., Bonso E., Dorigatti F., Longo D., Zaetta V., Mattarei M., et al. Effect of body weight loss on blood pressure after 6 years of follow-up in stage 1 hypertension. Am J Hypertens 19 (2006) 1103-1109
21. Langin D. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol Res 53 (2006) 482-491
22. Sprang S.R. G protein mechanisms: insights from structural analysis. Annu Rev Biochem 66 (1997) 639-678
23. Heximer S.P., Lim H., Bernard J.L., and Blumer K.J. Mechanisms governing subcellular localization and function of human RGS2. J Biol Chem 276 (2001) 14195-14203
24. Tang M., Wang G., Lu P., Karas R.H., Aronovitz M., Heximer S.P., et al. Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med 9 (2003) 1506-1512
25. Imamura T., Vollenweider P., Egawa K., Clodi M., Ishibashi K., Nakashima N., et al. G alpha-q/11 protein plays a key role in insulin-induced glucose transport in 3T3-L1 adipocytes. Mol Cell Biol 19 (1999) 6765-6774
26. Han J., Mark M.D., Li X., Xie M., Waka S., Rettig J., et al. RGS2 determines short-term synaptic plasticity in hippocampal neurons by regulating Gi/o-mediated inhibition of presynaptic Ca2+ channels. Neuron 51 (2006) 575-586
27. Tseng C.C., and Zhang X.Y. Role of regulator of G protein signaling in desensitization of the glucose-dependent insulinotropic peptide receptor. Endocrinology 139 (1998) 4470-4475
28. Hegele R.A., Brunt J.H., and Connelly P.M. Genetic variation on chromosome 1 associated with variation in body fat distribution in men. Circulation 92 (1995) 1089-1093
29. Nakayama T., Soma M., Kanmatsuse K., and Kokubun S. The microsatellite alleles on chromosome 1 associated with essential hypertension and blood pressure levels. J Hum Hypertens 18 (2004) 823-828
30. Langefeld C.D., Wagenknecht L.E., Rotter J.I., Williams A.H., Hokanson J.E., Saad M.F., et al. Linkage of the metabolic syndrome to 1q23-q31 in Hispanic families. The Insulin Resistance Atherosclerosis Study Family Study. Diabetes 53 (2004) 1170-1174
31. Hamet P., Merlo E., Seda O., Broeckel U., Tremblay J., Kaldunski M., et al. Quantitative founder-effect analysis of French Canadian families identifies specific loci contributing to metabolic phenotypes of hypertension. Am J Hum Genet. 76 (2005) 815-832
32. Poulsen P., Vaag A., Kyvik K., and Beck-Nielsen H. Genetic versus environmental aetiology of the metabolic syndrome among male and female twins. Diabetologia 44 (2001) 537-543
33. Heximer S.P., Knutsen R.H., Sun X., Kaltenbronn K.M., Rhee M.H., Peng N., et al. Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J Clin Invest 111 (2003) 445-452
34. Yang J., Kamide K., Kokubo Y., Takiuchi S., Tanaka C., Banno M., et al. Genetic variations of regulator of G-protein signaling 2 in hypertensive patients and in the general population. J Hypertens 23 (2005) 1497-1505
35. Riddle E.L., Rana B.K., Murthy K.K., Rao F., Eskin E., O'Connor D.T., et al. Polymorphisms and haplotypes of the regulator of G protein signaling-2 gene in normotensives and hypertensives. Hypertension 47 (2006) 415-420